DMS’ Public Health Innovations at the National Cancer Institute
DMS, a BRMi company, is at the forefront of leveraging artificial intelligence (AI) to enhance public health research, particularly in our support of the National Cancer Institute (NCI). Our advancements in applying large language models (LLMs) to structure vast quantities of unstructured clinical trial reports are transforming biomedical research by creating novel datasets that drive [...]